Atara Biotherapeutics, Inc. (ATRA)
NASDAQ · Healthcare
Atara Biotherapeutics, Inc. Shareholder Equity 2022–2025
Atara Biotherapeutics, Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Atara Biotherapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were -38.5M, a 60.42% decrease year-over-year.
- Atara Biotherapeutics, Inc. shareholder equity for 2025 were -38.5M, a 60.42% decrease from 2024.
- Atara Biotherapeutics, Inc. shareholder equity for 2024 were -97.3M, a 198.04% decrease from 2023.
- Atara Biotherapeutics, Inc. shareholder equity for 2023 were 99.2M, a 21.64% decrease from 2022.
- Atara Biotherapeutics, Inc. shareholder equity for 2022 were 126.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Atara Biotherapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-39 |
| 2024 | $-97 |
| 2023 | $99 |
| 2022 | $127 |
| Atara Biotherapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-39 |
| 2024-12-31 | $-97 |
| 2023-12-31 | $99 |
| 2022-12-31 | $127 |
Atara Biotherapeutics, Inc. Shareholder Equity — FAQ
Atara Biotherapeutics, Inc. (ATRA) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATRA's shareholder equity history?
The chart and table above show Atara Biotherapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.